Author: Margaret Moses Branch

FDA AVANDIA Hearing – Day Two update

07/14/10

The officials voting today were presented with multiple choice questions. Question three had a choice of A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia). B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia…. read more


FDA AVANDIA Hearing

07/13/10

Today, July 13th, 2010, the FDA is currently hosting a hearing regarding the dangerous drug Avandia. Please see our links in MEDIA to view recent news clips from CNN. As Albuquerque personal injury attorneys, we believe Avandia is harmful and consequently should be removed from the market. If you or a loved one has taken… read more




AVANDIA RECENT NEWS

Please see our Avandia information page to learn about the most up-to-date news on the harmful diabetes drug. The attorneys and lawyers at the Branch Law Firm can help you take action against the pharmaceutical giant Glaxo Smith Kline, makers of the diabetes drug Avandia; also known as Rosiglitazone.


DANGEROUS DRUG – Reglan

Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more




Grants Awarded To Study Medical Malpractice

Last week the Department of Health and Human Services announced millions of dollars in grants to states to address medical malpractice. These grants will go to state health departments, universities, and medical centers for demonstration projects designed to reduce injuries, decrease the numbers of lawsuits, improve doctor/patient communication, and lower liability insurance premiums. These funds… read more